| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |